Company News in the Life Science Industry

»

Reset 

Global Mabuprofen (CAS 83394-44-9) Market Report 2020

DUBLIN, March 26, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 27 Mar 2020

Sanofi: information concerning the total number of voting rights and shares, February 2020

Read more ››
By: GlobenewsWire - 26 Mar 2020

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of Management, and Grant of Restricted Stock Units and Warrants to Employees and a New Member

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Genmab A/S

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Vir Biotechnology, Inc.

electroCore Announces Changes to its Board of Directors

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  electroCore LLC

aTyr Pharma Announces Fourth Quarter and Full Year 2019 Results and Provides Corporate Update

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  aTyr Pharma Inc. | Pharmsynthez

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Xenon Pharmaceuticals Inc.

Celldex Provides Corporate Update and Reports Fourth Quarter and Year End 2019 Results

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Celldex Therapeutics, Inc.

Arbutus Announces Positive Preliminary Phase 1a/1b Clinical Trial Results for AB-729, a Proprietary GalNAc Delivered RNAi Compound in Development for People Living with Chronic Hepatitis B

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Arbutus Biopharma Corporation

Novan Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Novan, Inc.

IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  IGM Biosciences, Inc.

Equillium Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Equillium, Inc.

Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Genmab A/S

Translate Bio Provides MRT5005 Program Updates

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Translate Bio, Inc.

SEGRA ANNOUNCES APPOINTMENT OF JAMIE BLUNDELL AS CEO

Read more ››
By: GlobenewsWire - 26 Mar 2020

Abarca, Triple-S Accelerate Launch Of Puerto Rico's First Home Delivery Pharmacy Program During The COVID-19 Crisis

SAN JUAN, Puerto Rico, March 26, 2020 /PRNewswire/ -- Pharmacy benefit manager Abarca and Triple-S Management Corporation (NYSE: GTS), on behalf... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Triple-S Management Corporation

C² PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment

LUXEMBOURG, March 26, 2020 /PRNewswire/ -- C(2) PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020

Optiflux Dialyzers Show Mean Increase of Serum Albumin in Hemodialysis Patients

WALTHAM, Mass., March 26, 2020 /PRNewswire/ -- Hemodialysis patients treated with Optiflux® high flux single-use dialyzers experienced a mean increase in serum albumin levels, according to results from a recent clinical trial and separate retrospective analysis conducted by Fresenius Medical... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020

Innoplexus Announces Major Findings in Potential Combination Therapies for COVID-19

ESCHBORN, Germany, March 26, 2020 /PRNewswire/ -- Today, Innoplexus AG announced some first results in its artificial intelligence enabled search for a COVID-19 antiviral treatment.

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2020

Evolve BioSystems, Inc. Announces Collaboration with Janssen to Study the Impact of B. infantis EVC001 in the Reduction of Atopic Dermatitis

DAVIS, Calif., March 26, 2020 /PRNewswire/ -- Evolve BioSystems, Inc., a global leader dedicated to improving human health through the gut microbiome, today announced a collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson,... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies